The metabolomic detection of lung cancer biomarkers in sputum

Lung Cancer

Volumn 94, Issue , 2016, Pages 88-95

  Cameron, Simon J S ^a   Lewis, Keir E ^b,c   Beckmann, Manfred ^a   Allison, Gordon G ^a   Ghosal, Robin ^b   Lewis, Paul D ^c   Mur, Luis A J ^a  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

^b PRINCE PHILIP HOSPITAL   (United Kingdom)

^c SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Biomarkers; Gangliosides; Lung cancer; Metabolomics; Polyamines; Sputum

Indexed keywords

GANGLIOSIDE GM1; MERCAPTAMINE; PUTRESCINE; TUMOR MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; LUNG CANCER; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; NON SMALL CELL LUNG CANCER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SMALL CELL LUNG CANCER; SPUTUM; AGED; CLUSTER ANALYSIS; LUNG TUMOR; METABOLISM; METABOLOME; MIDDLE AGED; PROCEDURES; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CLUSTER ANALYSIS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LUNG NEOPLASMS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; RISK FACTORS; ROC CURVE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPUTUM;

EID: 84960448245     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2016.02.006     Document Type: Article

References (28)

1. WHO, Cancer Factsheet, WHO Fact Sheets, Number 2970. (2013). (accessed 29.05.3). http://www.who.int/mediacentre/factsheets/fs297/en/.
2. Jemal A., Siegel R., Xu J.Q., Ward E. Cancer statistics, 2010. CA: A Cancer J. Clin. 2010, 60:277-300. 10.1002/caac.20073.
3. Sutedja G. New techniques for early detection of lung cancer. Eur. Respir. J. 2003, 39:57s-66s. (accessed 25.02.14). http://www.ncbi.nlm.nih.gov/pubmed/12572703.
4. Jha P., Peto R., Zatonski W., Boreham J., Jarvis M.J., Lopez A.D. Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in england and wale, Poland, and North America. Lancet 2006, 368:367-370. 10.1016/S0140-6736(06) 68975-7.
5. Xie Y., Todd N.W., Liu Z., Zhan M., Fang H., Peng H., et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010, 67:170-176. 10.1016/j.lungcan.2009.04.004.
6. Shen J., Todd N.W., Zhang H., Yu L., Lingxiao X., Mei Y., et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab. Invest. 2011, 91:579-587. 10.1038/labinvest.2010.194.
7. Foss K.M., Sima C., Ugolini D., Neri M., Allen K.E., Weiss G.J. MiR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J. Thorac. Oncol. 2011, 6:482-488. 10.1097/JTO.0b013e318208c785.
8. Lewis P.D., Lewis K.E., Ghosal R., Bayliss S., Lloyd A.J., Wills J., et al. Evaluation of FTIR spectroscopy as a diagnostic tool for lung cancer using sputum. BMC Cancer 2010, 10:640. 10.1186/1471-2407-10-640.
9. Draper J., Lloyd A.J., Goodacre R., Beckmann M. Flow infusion electrospray ionisation mass spectrometry for high throughput, non-targeted metabolite fingerprinting: a review. Metabolomics 2012, 9:4-29. 10.1007/s11306-012-0449-x.
10. Collins G.S., Reitsma J.B., Altman D.G., Moons K.G.M. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015, 13:1. 10.1186/s12916-014-0241-z.
11. Lloyd A.J., Favé G., Beckmann M., Lin W., Tailliart K., Xie L., et al. Use of mass spectrometry fingerprinting to identify urinary metabolites after consumption of specific foods. Am. J. Clin. Nutr. 2011, 94:981-991. 10.3945/ajcn.111.017921.
12. Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C., Liu Y., et al. HMDB 3.0: the human metabolome database in 2013. Nucleic Acids Res. 2013, 41:D801-D807. 10.1093/nar/gks1065.
13. Manly B.F.J. Multivariate Statistical Methods: A Primer 1994, Chapman & Hall, London.
14. Jarvis R.M., Broadhurst D., Johnson H., O'Boyle N.M., Goodacre R. PYCHEM: a multivariate analysis package for python. Bioinformatics 2006, 22:2565-2566. 10.1093/bioinformatics/btl416.
15. Xia J., Mandal R., Sinelnikov I.V., Broadhurst D., Wishart D.S. MetaboAnalyst 2.0: a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012, 40:W127-W133. 10.1093/nar/gks374.
16. Xia J., Broadhurst D.I., Wilson M., Wishart D.S. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 2013, 9:280-299. 10.1007/s11306-012-0482-9.
17. Sumner L.W., Mendes P., Dixon R.A. Plant metabolomics: large-scale phytochemistry in the functional genomics era. Phytochemistry 2003, 62:817-836. 10.1016/S0031-9422(02)00708-2.
18. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314. 10.1126/science.123.3191.309.
19. Hori S., Nishiumi S., Kobayashi K., Shinohara M., Hatakeyama Y., Kotani Y., et al. A metabolomic approach to lung cancer. Lung Cancer 2011, 74:284-292. 10.1016/j.lungcan.2011.02.008.
20. Pegg A.E. Mammalian polyamine metabolism and function. IUBMB Life 2009, 61:880-894. 10.1002/iub.230.
21. Park M.H., Igarashi K. Polyamines and their metabolites as diagnostic markers of human diseases. Biomol. Ther. (Seoul) 2013, 21:1-9. 10.4062/biomolther.2012.097.
22. + in mitochondrial dysfunction and disease. Cell Calcium 2009, 45:643-650. 10.1016/j.ceca.2009.03.012.
23. Deng C., Zhang X., Li N. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 808:269-677. 10.1016/j.jchromb.2004.05.015.
24. Brezicka T., Bergman B., Olling S., Fredman P. Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues. Lung Cancer 2000, 28:29-36. 10.1016/S0169-5002(99)00107-5.
25. Krug L.M., Ragupathi G., Hood C., Kris M.G., Miller V.A., Allen J.R., et al. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin. Clin. Cancer Res. 2004, 10:6094-6100. CCR-04-0482. 10.1158/1078-0432.
26. Fuentes R., Allman R., Mason M. Ganglioside expression in lung cancer cell lines. Lung Cancer 1997, 18:21-33. 10.1016/S0169-5002(97)00049-4.
27. Rivera M.P., Mehta A.C., Wahidi M.M. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer. Chest 2013, 143:e142S-e165S. 10.1378/chest.12-2353.
28. Laxman B., Morris D.S., Yu J., Siddiqui J., Cao J., Mehra R., et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res. 2008, 68:645-649. CAN-07-3224. 10.1158/0008-5472.